InvestorsHub Logo
Followers 13
Posts 1544
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Monday, 09/18/2023 1:56:51 AM

Monday, September 18, 2023 1:56:51 AM

Post# of 1181
Iovance Biotherapeutics Director Wayne P. Rothbaum bought 5,000,000 shares of the company's stock in a transaction on Friday, September 15th. The shares were bought at an average cost of $5.30 per share, for a total transaction of $26,500,000.00.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IOVA News